Global Antibodies Market is poised to cross USD 161.897 Billion in 2021Posted by rohan on February 16th, 2018 According to the report Global Antibodies Market, published by Market Data Forecast, The Global Market was worth $ 95.217 Billion in 2016 and estimated to reach $ 161.897 Billion by the end of 2021 with a growing potential of 11.20 %. Antibodies are proteins that are produced in response to specific antigens by plasma cells. They are also called as immunoglobulin. These antibodies are used as diagnostics as well as Therapeutic purposes for several indications of diseases, including but not limited to, rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, Crohn’s disease, macular degeneration, hypercholesterolemia, and asthma. Owing to a number of product launches, antibodies market is projected to witness steady growth. Effective harmonisation of product development, approval and registration guidelines in some of the major markets, such as United States and European Union can speed up the research and development of antibody related products. Browse market data tables and in-depth TOC of the Global Antibodies Market to 2021 @ http://www.marketdataforecast.com/market-reports/global-antibodies-market-1177/ Major factors that are primarily driving the Global antibodies market are continuous development of innovative products, increased adoption rate to therapeutic antibodies in cost-sensitive markets, rise in chronic illnesses owing to population shift and increasing longevity, swift approval by regulatory authorities for breakthrough therapies, and adoption of diagnostic antibodies. Companies are adopting to various strategies, like expansion of products indications to sustain the dynamically growing market. High cost of treatment and side effects associated with antibodies treatment can hamper the growth of global antibodies market. Antibodies Market: Segmentation By Product Type
By Indication
End User
Application
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-antibodies-market-1177/request-sample Based on Indication, the market is segmented into Cancer, Auto immune diseases, Infectious diseases, cardiovascular diseases, and CNS disorders, others (Inflammatory, Microbial Diseases, & Other). Based on end users, the market is segmented into Hospitals/Clinics, Research institute, Diagnostics laboratories. Cancer indication type segment is predicted to account highest market share over the forecast period due to broad range applications of monoclonal antibodies for the treatment of various cancers. Based on Application, the market is segmented into Medical, Experimental. The Experimental segment is further categorized into Western blot, ELISA, Radioimmune Assays, immunofluorescence, others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry). Hospitals is predicted to account the highest share in global antibodies market during the forecast period. Based on Geography, the Antibodies market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Some of the major companies operating in global Antibodies market are Abbott Diagnostics, Novartis AG, Pfizer Inc., ThermoFisher Scientific Inc., Eli Lilly and company, A.G. Scientific, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., AbbVie Inc. Reasons to buy Antibodies Market Report:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions. Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206
Like it? Share it!More by this author |